Kazakstan Country Profile
CDC partnered with the Government of Kazakhstan in 1995 with the goal of strengthening the capacity to detect, prevent, and control diseases and respond to public health threats in Central Asia. In 2005, CDC began implementing HIV programs supported through the U.S. President’s Emergency Plan for AIDS Relief to help Kazakhstan achieve HIV epidemic control. These include evidence-based demonstration programs to identify cost-effective modes of service delivery and expanding HIV prevention and treatment services for populations at high-risk for acquiring HIV infection. CDC supports the Ministry of Health in the following areas: HIV prevention, including Medication Assisted Treatment of opioid addiction; HIV counseling and testing; laboratory strengthening; HIV care and treatment; and health systems.
Per Capita GNI
Under 5 Mortality
11/1,000 Live Births
Estimated HIV Prevalence
(Ages 15-49): (2020)
Estimated AIDS Deaths
TB Treatment Success Rate
Estimated TB Incidence
TB Mortality (HIV Related)
Estimated Orphans Due to AIDS
TB patients with known HIV-status who are HIV-positive
Reported Number Receiving Antiretroviral Therapy (ART)
The partnership between the U.S. Centers for Disease Control and Prevention (CDC) and the Government of Botswana began in 1995 with the goal of strengthening tuberculosis (TB) prevention and control through public health research. In 2000, the partnership grew to include HIV prevention, treatment, and strategic information program development to maximize the quality, coverage and impact of Botswana’s national response to the HIV epidemic. In 2013, CDC launched a four-year study, the Botswana Combination Prevention Project (BCPP), in partnership with the Botswana Ministry of Health and Harvard School of Public Health. The goal of the study was to evaluate whether coordinated and strengthened community-based HIV prevention methods prevent the spread of HIV better than the current methods. The BCPP program will conclude all in-country activities by August 2018.
CDC Botswana supports the Ministry of Health and Wellness (MOHW) through the President’s Emergency Plan for AIDS Relief (PEPFAR) Botswana and CDC headquarters. Our implementing partners (IPs) support Botswana’s antiretroviral treatment (ART), prevention of mother-to-child transmission (PMTCT) and TB programs, and work with the most impacted populations in targeted districts to support the scale-up and quality of services for both HIV-positive and negative individuals. Our HIV testing program is based in public facilities and communities and works to ensure pregnant women, people with TB and suspected TB, families and partners of people living with HIV, adolescent girls, young women, and men living with HIV know their HIV status.
CDC support to Botswana includes linkage to and retention in HIV treatment services, as well as quality of these services. The voluntary medical male circumcision (VMMC) program, through static sites and in- and out-of-school campaigns, helps to keep boys and men HIV-free. Our IPs enhance quality services through training, mentoring and supportive supervision and routine, comprehensive site monitoring visits, and remediation plans. CDC supports quality laboratory testing necessary for the diagnosis and treatment of people living with HIV and with TB. Our strategic information support is critical to the development, implementation and dissemination of population-based surveys as well as the quality of national health information systems and PEPFAR monitoring and evaluation systems. Our science program contributes generalizable knowledge related to HIV and TB. CDC supports the MOHW to enhance cervical cancer detection and prevention programs and with the establishment of the Botswana Public Health Institute.
Key Activities and Accomplishments
• Scale up of successful high-yield HIV testing modalities, including facility and community index testing, and identification and HIV testing of presumptive TB patients.
• MOHW’s universal ART treatment strategy, initiated in June, 2016, aims to provide antiretroviral treatment to all. CDC provides technical assistance to improve clinical services and ensure evidence-based modalities are implemented to enhance treatment initiation, adherence and retention for people living with HIV (PLHIV).
• The PMTCT program is one of Botswana’s success stories. It was grounded in CDC’s research findings. Now, CDC’s technical assistance provides training, mentoring and strengthening of existing clinical systems to support pregnant HIV-positive mothers and their HIV-exposed babies.
• Cervical cancer technical assistance is aimed to support the MOHW to scale up capacity in preventing cervical cancer in PLHIV. Capacity building includes policy development, training, and mentorship.
• The national Safe Male Circumcision (SMC) program was launched 2009. CDC supports the SMC program through technical assistance, service delivery, and demand creation.
• CDC strengthens the MOHW’s data systems and use by providing expertise and technical assistance to enhance data completeness and quality, improve surveillance systems, and increase data use.
• In collaboration with the MOHW and PEPFAR, CDC provided technical assistance for the construction and equipping of the National Public Health Laboratory (NPHL). The NPHL was built to establish laboratory capacity for routine surveillance and response to public health emergencies; to improve the availability, quality, and use of laboratory data for evidence-based decision making and planning in support of routine surveillance and epidemiologic investigations; and to foster collaboration between human, animal and environmental health laboratories. The NPHL hopes to provide a forum to promote partnerships as Botswana strives for a One Health approach to healthcare.
• Results from CDC’s BCPP study led to innovative testing, linkage to treatment, and retention strategies. Lessons learned in heath information system challenges, poor documentation of viral load testing, and other key operational and research questions have been rapidly translated into programs for maximum impact.
Despite being preventable and treatable, tuberculosis (TB) is now the leading infectious disease killer in the world, taking the lives of 1.6 million people each year.
For fifteen years, CDC has played a critical role in PEPFAR’s efforts to save millions of lives and transform the global HIV/AIDS response